In the BioHarmony Drug Report Database

"Preview" Icon


Asmanex Hfa, Asmanex Twisthaler, Elocon, Nasonex, Sinuva, Zimbus Breezhaler (mometasone furoate) is a small molecule pharmaceutical. Mometasone furoate was first approved as Asmanex Hfa on 1987-04-30. It is used to treat allergic rhinitis perennial, facial dermatoses, foot dermatoses, hand dermatoses, and inflammation amongst others in the USA. It has been approved in Europe to treat asthma. Elocon’s patents are valid until 2034-11-24 (FDA).


Trade Name


Zimbus Breezhaler

Common Name


mometasone furoate






allergic rhinitis perennial, asthma, facial dermatoses, foot dermatoses, hand dermatoses, inflammation, leg dermatoses, pruritus, scalp dermatoses

Drug Class


Corticosteroid; Glucocorticoid

Image (chem structure or protein)

Mometasone structure rendering